about
Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogsA rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USACurrent trends in the prevalence of Cryptococcus gattii in the United States and CanadaMolecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro.Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas.Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts.Case report: Sporotrichosis from the Northern Territory of Australia.Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesFirst reported Australian case of Cladophilophora arxii: features consistent with possible primary pulmonary chromoblastomycosis.Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States.Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, AustraliaCryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae.Cryptococcus gattii dispersal mechanisms, British Columbia, CanadaLocally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma.Biomaterials surfaces capable of resisting fungal attachment and biofilm formation.Protothecosis in hematopoietic stem cell transplantation: case report and review of previous cases.Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.Isolation of Cryptococcus laurentii from Canada Goose guano in rural upstate New York.Discovery of Aspergillus frankstonensis sp. nov. during environmental sampling for animal and human fungal pathogens.Changing epidemiology of candidaemia in Australia.Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.Azole resistance in canine and feline isolates of Aspergillus fumigatus.Multi-triazole-resistant Aspergillus fumigatus infections in Australia.Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak.Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass.What causes canine sino-nasal aspergillosis? A molecular approach to species identification.Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.The unicellular fungal tool RhoTox for risk assessments in groundwater systems.Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death.Neonatal tinea corporis due to a novel strain of Trichophyton rubrum.Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modifications.
P50
Q21133504-40589A38-D76D-42AA-9603-A674DD288B39Q24558831-295F627D-B198-4535-BF80-22D2669D2ED5Q24652835-2B0DF376-A1F0-4ADC-8834-9BBE95D63363Q28080670-F9148D7E-C811-4538-87F0-BABCDC2ABD0FQ33205317-7678640D-460F-47F3-B7B4-5BB71FADF7F1Q34097624-626002A4-FBFC-4AFC-8241-BF0E30860037Q34216198-D86F87D9-7C04-4CC0-BD0D-A2A50E2360B3Q34565901-EF7198D5-40D3-4FE3-BB1C-2B2FC030BC91Q34640367-D5CCB452-402A-4A7A-8EE3-764E9E7CA7E8Q35076896-8522EEBE-1B20-474D-9D67-C5FF664D2361Q35272714-91A4C7AF-E088-4D04-A1A2-6350D1B7C003Q35568246-AF1491F9-EA3E-445C-950D-986CA10207ADQ35689915-FB2B7A87-2AEE-4E81-B2C1-33CF6402B706Q35892221-726089E5-4CDB-4D88-8836-CF5EF4735DBAQ36018713-F3E1C71A-DB6D-4868-8E95-9F2C411C7998Q36158263-FD01A2AA-7CA7-452D-B493-2F3986808B1DQ36364064-4BD1C68C-0246-466F-A1F3-EADCD4CED81BQ36571990-6271C45B-F93D-4F3F-92DD-D6C1393ED6CDQ37009706-E9036D74-C446-488E-90DB-0F12F04B5C5BQ37302544-BC6636CE-FC24-46ED-AF45-80BD5F333BC2Q37454259-0C31C92A-301A-417A-81B8-09BA8850629FQ38161242-ACD97E6D-D2A7-46A1-B1F4-4C5A46784B61Q38209460-067DF7FC-D6D8-4758-A338-FC6AF8F18D37Q38663717-7E4460AE-0E7E-4B7A-B090-6051A4D1F064Q39776081-B8BFF29C-CE26-4056-9913-FFCA64299261Q40100310-B9736EEA-ABC7-4E81-BB90-98BC58D23589Q40330819-59A9063B-8456-43D1-8ACC-09D4624557B5Q40562677-C4C6F2ED-6C45-4E7A-BF7B-CA14DB79BD4AQ40990828-3A2D5B76-C236-4556-97CD-0ED79B5A9C42Q41321727-6714DDCC-2F7A-4EEF-9C58-0D44CB1EDA83Q41442637-B8E20404-317F-4DBC-9986-40F0E171D703Q41542809-A602A8BE-CEFE-402B-A2A1-599E2BF06838Q41901573-C7AC7964-DE9C-4E7C-A35C-90F5337366E1Q42046685-6942596D-EAF3-49ED-85CB-F20B8B225187Q42227452-1676FBF0-9C29-422F-BB03-CBF0144BFEFFQ42262049-2A5CD366-272C-4AE8-B98E-5BF5C33F512CQ46538052-037C49C8-239B-464E-A198-849B8EDF8133Q47660745-DF4E2715-F58D-4F05-A219-3B1A8112FA54Q47888272-F714EFA8-CCAA-417E-AFBE-6044CB45F881Q48670436-442DB247-306B-4BAF-BAC0-CA6608587DFA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sarah Kidd
@ast
Sarah Kidd
@en
Sarah Kidd
@es
Sarah Kidd
@nl
Sarah Kidd
@sl
type
label
Sarah Kidd
@ast
Sarah Kidd
@en
Sarah Kidd
@es
Sarah Kidd
@nl
Sarah Kidd
@sl
prefLabel
Sarah Kidd
@ast
Sarah Kidd
@en
Sarah Kidd
@es
Sarah Kidd
@nl
Sarah Kidd
@sl
P108
P1053
N-1362-2013
P106
P1153
7005272038
P21
P31
P3829
P496
0000-0002-5957-4178